238 related articles for article (PubMed ID: 8455096)
21. Epidemiology of beryllium sensitization and disease in nuclear workers.
Kreiss K; Mroz MM; Zhen B; Martyny JW; Newman LS
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):985-91. PubMed ID: 8214955
[TBL] [Abstract][Full Text] [Related]
22. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant.
Henneberger PK; Cumro D; Deubner DD; Kent MS; McCawley M; Kreiss K
Int Arch Occup Environ Health; 2001 Apr; 74(3):167-76. PubMed ID: 11355290
[TBL] [Abstract][Full Text] [Related]
23. Immunogenetic factors in beryllium sensitization and chronic beryllium disease.
Weston A; Snyder J; McCanlies EC; Schuler CR; Andrew ME; Kreiss K; Demchuk E
Mutat Res; 2005 Dec; 592(1-2):68-78. PubMed ID: 16054169
[TBL] [Abstract][Full Text] [Related]
24. Summary of historical beryllium uses and airborne concentration levels at Los Alamos National Laboratory.
Stefaniak AB; Weaver VM; Cadorette M; Puckett LG; Schwartz BS; Wiggs LD; Jankowski MD; Breysse PN
Appl Occup Environ Hyg; 2003 Sep; 18(9):708-15. PubMed ID: 12909539
[TBL] [Abstract][Full Text] [Related]
25. Immunology of chronic beryllium disease.
Samuel G; Maier LA
Curr Opin Allergy Clin Immunol; 2008 Apr; 8(2):126-34. PubMed ID: 18317020
[TBL] [Abstract][Full Text] [Related]
26. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
[TBL] [Abstract][Full Text] [Related]
27. Assessment of the beryllium lymphocyte proliferation test using statistical process control.
Cher DJ; Deubner DC; Kelsh MA; Chapman PS; Ray RM
Inhal Toxicol; 2006 Oct; 18(11):901-10. PubMed ID: 16864408
[TBL] [Abstract][Full Text] [Related]
28. Recent chronic beryllium disease in residents surrounding a beryllium facility.
Maier LA; Martyny JW; Liang J; Rossman MD
Am J Respir Crit Care Med; 2008 May; 177(9):1012-7. PubMed ID: 18244954
[TBL] [Abstract][Full Text] [Related]
29. Beryllium hypersensitivity and chronic beryllium lung disease.
Santo Tomas LH
Curr Opin Pulm Med; 2009 Mar; 15(2):165-9. PubMed ID: 19532033
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant.
Newman LS; Mroz MM; Maier LA; Daniloff EM; Balkissoon R
J Occup Environ Med; 2001 Mar; 43(3):231-7. PubMed ID: 11285871
[TBL] [Abstract][Full Text] [Related]
31. Ultrafine beryllium number concentration as a possible metric for chronic beryllium disease risk.
McCawley MA; Kent MS; Berakis MT
Appl Occup Environ Hyg; 2001 May; 16(5):631-8. PubMed ID: 11370941
[TBL] [Abstract][Full Text] [Related]
32. [Clinical aspects and diagnosis of chronic berylliosis--a case report].
Bargon J; Rust M; Kronenberger H; Buhl R; Meier-Sydow J
Pneumologie; 1990 Feb; 44 Suppl 1():320-1. PubMed ID: 2367406
[TBL] [Abstract][Full Text] [Related]
33. Exposure pathway assessment at a copper-beryllium alloy facility.
Day GA; Dufresne A; Stefaniak AB; Schuler CR; Stanton ML; Miller WE; Kent MS; Deubner DC; Kreiss K; Hoover MD
Ann Occup Hyg; 2007 Jan; 51(1):67-80. PubMed ID: 16844720
[TBL] [Abstract][Full Text] [Related]
34. Systematic review: Progression of beryllium sensitization to chronic beryllium disease.
Seidler A; Euler U; Müller-Quernheim J; Gaede KI; Latza U; Groneberg D; Letzel S
Occup Med (Lond); 2012 Oct; 62(7):506-13. PubMed ID: 22705916
[TBL] [Abstract][Full Text] [Related]
35. Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed.
Henneberger PK; Goe SK; Miller WE; Doney B; Groce DW
J Occup Environ Hyg; 2004 Oct; 1(10):648-59. PubMed ID: 15631056
[TBL] [Abstract][Full Text] [Related]
36. Beryllium medical surveillance at a former nuclear weapons facility during cleanup operations.
Sackett HM; Maier LA; Silveira LJ; Mroz MM; Ogden LG; Murphy JR; Newman LS
J Occup Environ Med; 2004 Sep; 46(9):953-61. PubMed ID: 15354061
[TBL] [Abstract][Full Text] [Related]
37. Use of proliferation tests to evaluate the effects of complexing agents on beryllium toxicity.
Stephan CH; Sauvé S; Fournier M; Brousseau P
J Appl Toxicol; 2009 Jan; 29(1):27-35. PubMed ID: 18785683
[TBL] [Abstract][Full Text] [Related]
38. [Berylliosis in Italy: a case of "sarcoidosis" under the threshold limit value].
Contini S; Mattioli G; Berretta F; Bergamaschi A; Sullotto F; Spigo A; Verniano P; Amicosante M
Med Lav; 2006; 97(4):592-6. PubMed ID: 17017386
[TBL] [Abstract][Full Text] [Related]
39. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant.
Kreiss K; Mroz MM; Zhen B; Wiedemann H; Barna B
Occup Environ Med; 1997 Aug; 54(8):605-12. PubMed ID: 9326165
[TBL] [Abstract][Full Text] [Related]
40. A Cluster of Beryllium Sensitization Traced to the Presence of Beryllium in Concrete Dust.
Frye BC; Quartucci C; Rakete S; Grubanovic A; Höhne K; Mangold F; Gieré R; Müller-Quernheim J; Zissel G
Chest; 2021 Mar; 159(3):1084-1093. PubMed ID: 32926872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
